|
Market Closed -
Nasdaq
16:00:00 2026-08-13 EDT
|
5-day change | 1st Jan Change | ||
| 19.45 USD | -0.51% |
|
+3.24% | +7.10% |
| 08-06 | Avalo Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 07-17 | Avalo Therapeutics Says Some Shareholders May Sell Up to 128,189 Shares | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.51% | +3.24% | +1.25% | -2.46% | +7.10% | +107.80% | -36.64% | -99.77% | -99.83% | 1.05B | |
| +2.07% | +10.05% | +31.65% | +47.13% | +79.09% | +77.41% | +106.53% | +16.62% | - | 70.1B | |
| -0.87% | +0.77% | -1.23% | +8.05% | +5.25% | +36.57% | +65.91% | +182.34% | +5,422.69% | 54.93B | |
| -4.50% | +27.58% | +9.27% | +8.91% | -27.41% | +3.55% | +463.22% | +428.14% | +960.71% | 28.89B | |
| +0.04% | +12.56% | +20.44% | +35.67% | +45.42% | +54.67% | +5.47% | -61.93% | - | 23.9B | |
| -0.67% | -0.07% | +0.69% | -1.64% | -3.24% | -17.01% | -13.84% | -75.37% | - | 23.3B | |
| +0.35% | +8.24% | +12.45% | +125.44% | +241.04% | +252.94% | +466.50% | +1,800.42% | +864.12% | 18.41B | |
| -0.59% | +7.03% | +8.38% | +18.25% | -0.10% | +46.32% | -20.56% | -31.03% | +78.89% | 18.77B | |
| -0.57% | +6.85% | +1.74% | +14.04% | +33.99% | +30.20% | +580.70% | - | - | 16.1B | |
| +0.46% | -10.74% | -10.42% | +2.33% | +15.47% | +33.36% | +135.18% | +181.64% | +374.77% | 12.48B | |
| -1.90% | -1.52% | +12.03% | +8.29% | +28.92% | +380.84% | +196.67% | +43.15% | +1,336.07% | 12.32B | |
| -5.38% | -1.31% | -5.46% | -0.57% | -12.87% | +41.33% | +195.96% | +493.90% | +6,637.98% | 12.39B | |
| -7.28% | +3.47% | -8.20% | -26.12% | -19.95% | -45.49% | +713.95% | +76.77% | +110.18% | 12.05B | |
| +1.47% | +8.48% | +6.53% | -20.31% | -8.32% | -33.80% | +208.79% | +135.99% | - | 11.98B | |
| -2.90% | -6.85% | -13.46% | -1.82% | +15.60% | +114.08% | +124.27% | +126.49% | +504.53% | 10.52B | |
| +0.24% | -0.06% | -1.90% | -13.07% | +14.58% | +25.19% | +119.41% | -26.34% | - | 8.99B | |
| -2.15% | -2.40% | +4.21% | +35.73% | +210.90% | +540.97% | +714.80% | -34.50% | -11.44% | 9.18B | |
| -0.02% | +0.52% | +1.03% | +128.77% | +81.40% | +196.49% | +411.29% | +323.05% | - | 8.96B | |
| -1.32% | +5.26% | +1.12% | +8.94% | +27.57% | +96.20% | +24.68% | +120.78% | - | 8.88B | |
| -1.16% | +5.52% | -6.93% | -5.79% | +286.36% | +209.72% | +318.03% | -32.89% | - | 8.2B | |
| Average | -1.26% | +5.50% | +3.16% | +18.49% | +51.04% | +107.57% | +239.02% | +187.76% | +1,470.79% | 18.57B | |
| Weighted average by Cap. | -0.77% | +6.73% | +8.38% | +23.25% | +44.82% | +80.69% | +201.63% | +193.40% | +2,370.97% |
- Stock Market
- Stocks
- AVTX Stock
- Sector Avalo Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
